Koji Tomita
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 33
- Fungal Biology and Applications 9
- Microbiology top 5%
- Biotechnology top 2%
- Organic Chemistry top 5%
- Molecular Biology top 10%
- Renal and related cancers 8
-
- Renal cell carcinoma treatment 17
-
- MRI in cancer diagnosis 11
-
- Pancreatic function and diabetes 10
-
- Diabetes Management and Research 7
-
- Diabetes and associated disorders 7
- Co-authors
- MASATAKA KONISHITOSHIKAZU OKITakeo MiyakiKoko SugawaraHideo KameiYuji NishiyamaHiroshi KawaguchiHaruaki Yamamoto
- Journals
- The Journal of Antibiotics (44 papers)Diagnostic and Interventional Imaging (8 papers)Diabetes Research and Clinical Practice (4 papers)
- Partner nations
- JapanGermanyUnited Kingdom
In The Last Decade
Koji Tomita
117 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 128
- Pharmacology 634
- Microbiology 23
- Biotechnology 253
- Organic Chemistry 574
- Molecular Biology 1.2k
Countries citing papers authored by Koji Tomita
This map shows the geographic impact of Koji Tomita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Tomita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Tomita more than expected).
Fields of papers citing papers by Koji Tomita
This network shows the impact of papers produced by Koji Tomita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Tomita. The network helps show where Koji Tomita may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Koji Tomita, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 14 | |
| 10 | 2019 | 24 | |
| 11 | 2017 | 8 | |
| 12 | 2016 | 10 | |
| 13 | 2012 | 68 | |
| 14 | 1996 | 108 | |
| 15 | 1996 | 21 | |
| 16 | 1993 | 20 | |
| 17 | 1993 | 23 | |
| 18 | 1992 | 169 | |
| 19 | 1991 | 43 | |
| 20 | 1989 | 11 |
About Koji Tomita
Koji Tomita is a scholar working on Microbiology, Pharmacology and Biotechnology, having authored 125 papers that have together received 2.6k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (33 papers), Renal cell carcinoma treatment (17 papers), MRI in cancer diagnosis (11 papers), Pancreatic function and diabetes (10 papers), Fungal Biology and Applications (9 papers), Renal and related cancers (8 papers), Diabetes Management and Research (7 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Pharmacology (634 citations), Microbiology (23 citations) and Biotechnology (253 citations). Koji Tomita has collaborated with scholars based in Japan, Germany and United Kingdom. Frequent co-authors include MASATAKA KONISHI, TOSHIKAZU OKI, Takeo Miyaki, Koko Sugawara, Hideo Kamei, Yuji Nishiyama, Hiroshi Kawaguchi, Haruaki Yamamoto, Hiroshi Kawaguchi and Minoru Hanada. Their work appears in journals such as The Journal of Antibiotics, Diagnostic and Interventional Imaging, Diabetes Research and Clinical Practice, Diabetologia and International Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.